新冠肺炎重型、危重型患者护理规范

2020-02-29 中华人民共和国国家卫生健康委员会 中华人民共和国国家卫生健康委员会官网

做好新型冠状病毒肺炎重症患者的密切监测和整体护理,发挥好医疗与护理的协同作用,是进一步提高治愈率,降低病亡率的有效路径,有必要建立新型冠状病毒肺炎重症病区的护理统一流程标准和评估,指导各地标准化、规范

中文标题:

新冠肺炎重型、危重型患者护理规范

英文标题:

新冠肺炎重型、危重型患者护理规范

发布日期:

2020-02-29

简要介绍:

做好新型冠状病毒肺炎重症患者的密切监测和整体护理,发挥好医疗与护理的协同作用,是进一步提高治愈率,降低病亡率的有效路径,有必要建立新型冠状病毒肺炎重症病区的护理统一流程标准和评估,指导各地标准化、规范化、同质化开展重症患者护理工作。在总结湖北省重型、危重型患者临床护理有关经验的基础上,国家卫健委组织专家制定了《新冠肺炎重型、危重型患者护理规范》(以下简称《护理规范》)。《护理规范》主要包括三方面内容,一是提出新冠肺炎ICU病区设置、设备设施配备基本要求和ICU护理人力配备与排班基本原则。二是简要介绍重型、危重型患者临床特点,通过加强重症预警监测,及时、尽早识别病情变化。三是梳理了氧气疗法等8种与新型冠状病毒肺炎重症患者护理密切相关的护理操作,明确护理要点,指导规范开展临床护理工作。

相关资料下载:
[AttachmentFileName(sort=1, fileName=)] GetToolGuiderByIdResponse(projectId=1, id=b02d91c0018e36a6, title=新冠肺炎重型、危重型患者护理规范, enTitle=新冠肺炎重型、危重型患者护理规范, guiderFrom=中华人民共和国国家卫生健康委员会官网, authorId=0, author=, summary=做好新型冠状病毒肺炎重症患者的密切监测和整体护理,发挥好医疗与护理的协同作用,是进一步提高治愈率,降低病亡率的有效路径,有必要建立新型冠状病毒肺炎重症病区的护理统一流程标准和评估,指导各地标准化、规范, cover=https://medsci-open-files.oss-cn-shanghai.aliyuncs.com/hospital-840135__340_1583646345000.jpg, journalId=0, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Sat Feb 29 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">做好新型冠状病毒肺炎重症患者的密切监测和整体护理,发挥好医疗与护理的协同作用,是进一步提高治愈率,降低病亡率的有效路径,有必要建立新型冠状病毒肺炎重症病区的护理统一流程标准和评估,指导各地标准化、规范化、同质化开展重症患者护理工作。在总结湖北省重型、危重型患者临床护理有关经验的基础上,国家卫健委组织专家制定了《新冠肺炎重型、危重型患者护理规范》(以下简称《护理规范》)。</span><span style="color: #373737;">《护理规范》主要包括三方面内容,一是提出新冠肺炎ICU病区设置、设备设施配备基本要求和ICU护理人力配备与排班基本原则。二是简要介绍重型、危重型患者临床特点,通过加强重症预警监测,及时、尽早识别病情变化。三是梳理了氧气疗法等8种与新型冠状病毒肺炎重症患者护理密切相关的护理操作,明确护理要点,指导规范开展临床护理工作。</span><span style="color: #ffffff;">(</span></p>, tagList=[TagDto(tagId=8216, tagName=新型冠状病毒感染), TagDto(tagId=32158, tagName=重症护理)], categoryList=[CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=79, categoryName=护理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=7067, guiderKeyword=新型冠状病毒, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4596, appHits=136, showAppHits=0, pcHits=1439, showPcHits=4500, likes=0, shares=13, comments=4, approvalStatus=1, publishedTime=Tue Mar 10 17:41:59 CST 2020, publishedTimeString=2020-02-29, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=6, createdBy=null, createdName=qiushida2, createdTime=Sun Mar 08 13:46:05 CST 2020, updatedBy=1, updatedName=小M, updatedTime=Fri Jan 05 13:33:23 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=)])
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1179423, encodeId=ba7d11e94238c, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b586387467, createdName=ms6000001889337521, createdTime=Fri Dec 31 21:45:13 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012503, encodeId=fcf91012503ed, content=指导临床工作,点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54e55588035, createdName=ms3000000113459996, createdTime=Sun Aug 29 10:52:23 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881266, encodeId=39ce88126601, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=431a5412537, createdName=ms1000001973860877, createdTime=Mon Aug 31 08:58:31 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2021-12-31 ms6000001889337521

    有用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1179423, encodeId=ba7d11e94238c, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b586387467, createdName=ms6000001889337521, createdTime=Fri Dec 31 21:45:13 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012503, encodeId=fcf91012503ed, content=指导临床工作,点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54e55588035, createdName=ms3000000113459996, createdTime=Sun Aug 29 10:52:23 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881266, encodeId=39ce88126601, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=431a5412537, createdName=ms1000001973860877, createdTime=Mon Aug 31 08:58:31 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2021-08-29 ms3000000113459996

    指导临床工作,点赞

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1179423, encodeId=ba7d11e94238c, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b586387467, createdName=ms6000001889337521, createdTime=Fri Dec 31 21:45:13 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012503, encodeId=fcf91012503ed, content=指导临床工作,点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54e55588035, createdName=ms3000000113459996, createdTime=Sun Aug 29 10:52:23 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881266, encodeId=39ce88126601, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=431a5412537, createdName=ms1000001973860877, createdTime=Mon Aug 31 08:58:31 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2020-08-31 ms1000001973860877

    0

拓展阅读

新型冠状病毒感染的肺炎防控方案(第二版)

中华人民共和国国家卫生健康委员会 · 2020-01-22

新型冠状病毒感染的肺炎诊疗方案(试行第三版)

中华人民共和国国家卫生健康委员会 · 2020-01-23

预防 2019 年新型冠状病毒 (2019-nCoV) 传播给家庭和社区中其他人的暂行指南

美国疾病控制与预防中心(CDC,Centers for Disease Control and Prevention) · 2020-01-26

新型冠状病毒感染的肺炎诊疗方案(试行第五版)

中华人民共和国国家卫生健康委员会 · 2020-02-05